Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242683 · ClinicalTrials.gov registry record · Phase 2
Vivamos Activos Fair Oaks Program for Weight Loss in Low Income Latinos
A Phase 2 study of Obesity, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 207
- Enrollment target
- 4
- Study locations
NCT01242683: Completed Phase 2 study of Obesity, sponsored by Stanford University.
NCT01242683 is a Phase 2 study of Obesity that has completed, run by Stanford University. The registered enrollment target is 207 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242683, a Phase 2 study of Obesity, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 207 participants
- Enrollment target
- 4
- Study locations
Study Summary
Physician-based primary care has thus far failed to address the obesity epidemic. In this randomized clinical trial of 200 obese patients with heart disease risk factors, the investigators will evaluate the impact of nurse and dietitian case management on weight loss and weight maintenance, as an adjunct to physician care. In addition, the investigators will test the incremental benefit of an environmental support strategy using community health workers to help patients navigate their home and neighborhood environments to achieve weight loss. The innovative intervention model developed and evaluated in this project has the potential to provide a blueprint for successful primary care-based obesity services
Conditions Studied
Interventions
- BEHAVIORAL Vivamos Activos Fair Oaks Program
Study Locations (4)
California
- Palo Alto Medical Foundation Research Institute - Palo Alto
- San Mateo Medical Center, Fair Oaks Adult Clinic - Redwood City
- El Concilio of San Mateo - San Mateo
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2008-05 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
What the finished NCT01242683 record still lists
NCT01242683 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Vivamos Activos Fair Oaks Program is the first listed.
NCT01242683 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01242683 about?
NCT01242683 is a clinical study titled "Vivamos Activos Fair Oaks Program for Weight Loss in Low Income Latinos". Physician-based primary care has thus far failed to address the obesity epidemic. In this randomized clinical trial of 200 obese patients with heart disease risk factors, the investigators will evaluate the impact of nurse and dietitian case management on weight loss and weight maintenance, as an ad...
What is the current status of trial NCT01242683?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 207 participants. The study started on 2008-05. Estimated completion is 2013-10.
What conditions does trial NCT01242683 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01242683?
The interventions under investigation include: Vivamos Activos Fair Oaks Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01242683?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01242683 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01242683's enrollment target sits among peer trials
207 307th of 1053 higher than 746 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia